Cargando…

Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?

Detalles Bibliográficos
Autores principales:	Gkika, Eleni, Vach, Werner, Adebahr, Sonja, Schimek-Jasch, Tanja, Brenner, Anton, Brunner, Thomas Baptist, Kaier, Klaus, Prasse, Antje, Müller-Quernheim, Joachim, Grosu, Anca-Ligia, Zissel, Gernot, Nestle, Ursula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785000/ https://www.ncbi.nlm.nih.gov/pubmed/29370272 http://dx.doi.org/10.1371/journal.pone.0192058

Ejemplares similares

Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
por: Gkika, Eleni, et al.
Publicado: (2017)

Simultaneous integrated protection: A new concept for high-precision radiation therapy
por: Brunner, Thomas B., et al.
Publicado: (2016)

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Visualization of 4D multimodal imaging data and its applications in radiotherapy planning
por: Schlachter, Matthias, et al.
Publicado: (2017)

FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy
por: Carles, Montserrat, et al.
Publicado: (2021)

CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II
por: Pechkovsky, Dmitri V, et al.
Publicado: (2005)

Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies
por: Gkika, Eleni, et al.
Publicado: (2021)

CC-Chemokine Ligand 18 Induces Epithelial to Mesenchymal Transition in Lung Cancer A549 Cells and Elevates the Invasive Potential
por: Ploenes, Till, et al.
Publicado: (2013)

Serum Level of CC-Chemokine Ligand 18 Is Increased in Patients with Non-Small-Cell Lung Cancer and Correlates with Survival Time in Adenocarcinomas
por: Plönes, Till, et al.
Publicado: (2012)

Immunohistochemistry and Radiomic Features for Survival Prediction in Small Cell Lung Cancer
por: Gkika, Eleni, et al.
Publicado: (2020)

Lung Collagens Perpetuate Pulmonary Fibrosis via CD204 and M2 Macrophage Activation
por: Stahl, Mirjam, et al.
Publicado: (2013)

Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2015)

A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatment
por: Duda, Dan, et al.
Publicado: (2023)

User Interaction in Semi-Automatic Segmentation of Organs at Risk: a Case Study in Radiotherapy
por: Ramkumar, Anjana, et al.
Publicado: (2015)

Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer—A Secondary Analysis of the PET Plan Trial
por: Gkika, Eleni, et al.
Publicado: (2020)

Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) – protocol of a randomized phase II trial (NOA 10/ARO 2013-1)
por: Oehlke, Oliver, et al.
Publicado: (2016)

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
por: Gkika, Eleni, et al.
Publicado: (2023)

Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis
por: Bettinger, Dominik, et al.
Publicado: (2018)

The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer
por: Gkika, Eleni, et al.
Publicado: (2020)

Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10
por: Murakami, Takashi, et al.
Publicado: (2003)

Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review
por: Korbecki, Jan, et al.
Publicado: (2020)

FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
por: Carles, Montserrat, et al.
Publicado: (2021)

Patient reported outcomes based on EQ-5D-5L questionnaires in head and neck cancer patients: a real-world study
por: Sprave, Tanja, et al.
Publicado: (2022)

The Role of CC-Chemokines in the Regulation of Angiogenesis
por: Ridiandries, Anisyah, et al.
Publicado: (2016)

The roles of CC chemokines in response to radiation
por: Wang, Lei, et al.
Publicado: (2022)

Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours
por: Scotton, C, et al.
Publicado: (2001)

Roflumilast-N-oxide Induces Surfactant Protein Expression in Human Alveolar Epithelial Cells Type II
por: Höhne, Kerstin, et al.
Publicado: (2012)

Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist
por: Isaikina, Polina, et al.
Publicado: (2021)

Bronchoalveolar Lavage Fluid Reflects a T(H)1-CD21(low) B-Cell Interaction in CVID-Related Interstitial Lung Disease
por: Friedmann, David, et al.
Publicado: (2021)

CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors
por: Santoni, Matteo, et al.
Publicado: (2014)

Selected CC and CXC chemokines in children with atopic asthma
por: Machura, Edyta, et al.
Publicado: (2016)

Role of CC-chemokine ligand 2 in gynecological cancer
por: Zhang, Jia-Jia, et al.
Publicado: (2022)

Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8
por: Sun, Dawei, et al.
Publicado: (2023)

Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study
por: Gkika, Eleni, et al.
Publicado: (2022)

Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) – protocol for a multi-center, single-arm phase IIa trial
por: Frye, Björn C., et al.
Publicado: (2020)

The role of CC-chemokine receptor 4 in murine polymicrobial sepsis
por: Maier, Stefan, et al.
Publicado: (2007)

Study of CC chemokine receptor 5 in renal allograft rejection
por: Ghosh, R., et al.
Publicado: (2013)

CC Chemokine Receptor 5: The Interface of Host Immunity and Cancer
por: de Oliveira, Carlos Eduardo Coral, et al.
Publicado: (2014)

Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists
por: Zheng, Yi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d7p8giv063ldonsqu5qp76d3fb